[go: up one dir, main page]

AR062166A1 - PAIN TREATMENT - Google Patents

PAIN TREATMENT

Info

Publication number
AR062166A1
AR062166A1 ARP070103383A ARP070103383A AR062166A1 AR 062166 A1 AR062166 A1 AR 062166A1 AR P070103383 A ARP070103383 A AR P070103383A AR P070103383 A ARP070103383 A AR P070103383A AR 062166 A1 AR062166 A1 AR 062166A1
Authority
AR
Argentina
Prior art keywords
pain
treatment
medicament
milnacipran
pramipexole
Prior art date
Application number
ARP070103383A
Other languages
Spanish (es)
Inventor
Ronald Rosenburg
Ralph Newton Miller
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38626845&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR062166(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of AR062166A1 publication Critical patent/AR062166A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Medicamento para el tratamiento del dolor, en particular la fibromialgia. El medicamento comprende la administracion de pramipexol y milnacipran. El medicamento es una combinacion de pramipexol y milnacipran, que se puede utilizar en una combinacion de dosis fijas como también en una combinacion en dosis libres. La invencion también se refiere a la elaboracion de un medicamento para el tratamiento del dolor, en particular la fibromialgia, que comprende dicho medicamento y un método de tratamiento de dolor, en particular la fibromialgia, que comprende dicho medicamento. Reivindicacion 1: Uso de una cantidad eficaz desde el punto de vista analgésico de pramipexol y una cantidad eficaz desde el punto de vista analgésico de milnacipran para la preparacion de un medicamento para el tratamiento del dolor.Medicine for the treatment of pain, in particular fibromyalgia. The drug comprises the administration of pramipexole and milnacipran. The drug is a combination of pramipexole and milnacipran, which can be used in a combination of fixed doses as well as in a combination in free doses. The invention also relates to the preparation of a medicament for the treatment of pain, in particular fibromyalgia, comprising said medicament and a method of pain treatment, in particular fibromyalgia, comprising said medicament. Claim 1: Use of an analgesic effective amount of pramipexole and an analgesic effective amount of milnacipran for the preparation of a medicament for the treatment of pain.

ARP070103383A 2006-08-02 2007-08-01 PAIN TREATMENT AR062166A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83517306P 2006-08-02 2006-08-02

Publications (1)

Publication Number Publication Date
AR062166A1 true AR062166A1 (en) 2008-10-22

Family

ID=38626845

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070103383A AR062166A1 (en) 2006-08-02 2007-08-01 PAIN TREATMENT

Country Status (4)

Country Link
AR (1) AR062166A1 (en)
CL (1) CL2007002215A1 (en)
TW (1) TW200816997A (en)
WO (1) WO2008015163A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6602911B2 (en) * 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia

Also Published As

Publication number Publication date
TW200816997A (en) 2008-04-16
WO2008015163A1 (en) 2008-02-07
CL2007002215A1 (en) 2008-04-11

Similar Documents

Publication Publication Date Title
CO6220962A2 (en) NOVEDOUS THERAPEUTIC USES OF 1- [2 (2,4-DIMETHYLPHENYLSULPHANIL) PHENYL] -PIPERAZINE
PE20142319A1 (en) MULTIPLE SCLEROSIS TREATMENT WITH A COMBINATION OF LAQUINIMOD AND GLATIRAMER ACETATE
PE20170302A1 (en) USE OF PRIDOPIDINE IN HIGH DOSES FOR THE TREATMENT OF HUNTINGTON DISEASE
AR065580A1 (en) IMPROVEMENTS IN MEDICINAL COMPOSITIONS OR RELATED TO THE SAME
BRPI0513200A (en) use of an anti-igf-1r antibody in the preparation of a medicament for combined treatment for nonhematological malignancies
AR060836A1 (en) A TRANS-MUCOSA DISK TO ADMINISTER AN ACTIVE AGENT, A TRANS-MUCOSA COMPOSITION AND THE METHOD OF ADMINISTRATION OBTAINED
MX386380B (en) Rapid-dissolving oral vaccine dose form using starch.
AR096892A1 (en) A PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF MELANOMA
PE20150161A1 (en) USE OF HIGH DOSE LAQUINIMOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS
MX367209B (en) AN INTRAVENOUS COMPOSITION INCLUDING IBUPROFEN AND PARACETAMOL IN COMBINATION.
AR073265A1 (en) USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE PREVENTION OF ICTUS OR TRANSITIONAL ISCHEMICAL ATTACK
AR061166A1 (en) PHARMACEUTICAL COMPOSITIONS FOR SUSTAINED RELEASE OF PHENYLPHERINE
PE20211199A1 (en) USE OF REBOXETIN FOR THE TREATMENT OF NARCOLEPSY
AR065582A1 (en) IMPROVEMENTS IN MEDICINAL COMPOSITIONS OR RELATED TO THE SAME
AR065139A1 (en) MEDICATION FOR THE TREATMENT OF ENDOMETRIOSIS
ECSP10010464A (en) USE OF RANOLAZINE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
CR10407A (en) LIQUID DRUG FORMULATION.
ECSP10010567A (en) Use of dronedarone to prepare a medication for the treatment of patients with arrhythmia and who have an increase in creatinine level due to the administration of dronedarone
AR075866A1 (en) A DOSE OF AVE5026 FOR THE TREATMENT OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH SEVERE RENAL DETERIORATION. USE. PHARMACEUTICAL COMPOSITION
MX2021003030A (en) Pharmaceutical compositions suitable for articular delivery and use thereof in treatment of joint pain.
TW200628182A (en) Injection device for administering a medication liquid
BRPI0520797A2 (en) pharmaceutical dosage form, pharmaceutical tablet, method for breaking a pharmaceutical tablet, method of administering a partial dose of a drug contained in a pharmaceutical tablet, method for reducing the risk or preventing patient confusion in a treatment, compressed pharmaceutical tablet, method for breaking a pressed pharmaceutical tablet and method for creating an accurate amount of a drug
AR062166A1 (en) PAIN TREATMENT
AR086491A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING FEXOFENADINE
AR063206A1 (en) PAIN TREATMENT

Legal Events

Date Code Title Description
FB Suspension of granting procedure